Generic drug company Hikma is bolstering its portfolio by acquiring parts of Xellia Pharmaceuticals’ finished dosage form business in the US.
This includes Hikma taking …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A recent study in Nature Medicine found that LM11A-31, targeting the p75 neurotrophin receptor, is safe and shows promise in slowing Alzheimer’s disease progression. The
Chaim Linhart, Chaim, Co-founder and CTO at Ibex Medical Analytics Artificial intelligence (AI) technology is set to transform the field of diagnostics, similar to how
Recovery from a cardiac-related hospitalization requires coordinated, timely care to prevent a return to the hospital for an avoidable readmission. A new study concludes that